Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

Cystic fibrosis (CF) patients develop chronic airway infections with Pseudomonas aeruginosa (PA), Pseudomonas aeruginosa synthesized lipopolysaccharide (LPS) with a variety of penta- and hexa-acylated lipid A structures under different environmental conditions. CF patient PA synthesized LPS with specific Lipid A structures indicating unique recognition of the CF airway environment. CF-specific Lipid A forms containing palmitate and aminoarabinose were associated with resistance to cationic antimicrobial peptides and increased inflammatory responses, indicating that they are likely to be involved in airway disease.